|
Eric Bolesh is a research team leader with Cutting Edge Information, where his work primarily focuses on pharmaceutical commercialization and marketing. As the author of CEI's reports on late-stage brand management and product launch, he also serves as a lead consultant for CEI's customized research on marketing-related topics. Mr. Bolesh's expertise goes beyond commercialization to include counter-generics strategies, business development and licensing, and long-term brand management. He has also spearheaded CEI's exploration of the medical technology and devices sector. Mr. Bolesh and his work have appeared in a range of media, including leading pharmaceutical publications such as Pharmaceutical Executive, MedAdNews and PharmaVoice as well as general business media such as The Wall Street Journal, The New York Times and National Public Radio's Marketplace. Mr. Bolesh is an honors graduate of Harvard University. | 